Categories AlphaGraphs, Consumer, Earnings

CPB Earnings: Key quarterly highlights from Campbell Soup’s Q2 2024 financial results

Campbell Soup Company (NYSE: CPB) reported second quarter 2024 earnings results today.

Net sales totaled $2.5 billion, down 1% on both a reported and organic basis compared to the same period a year ago.

Net earnings attributable to Campbell Soup Company were $203 million, or $0.68 per share, compared to $232 million, or $0.77 per share, last year. Adjusted EPS remained flat at $0.80.

Both revenue and earnings surpassed estimates.

For fiscal year 2024, net sales growth is expected to be down 0.5% to up 1.5% compared to the previous year. Organic sales growth is expected to be flat to up 2% versus last year. Adjusted EPS is expected to range between $3.09-3.15.

The stock dipped 1% in premarket hours on Wednesday, following the announcement.

Prior performance

Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top